SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 61 filers reported holding SUTRO BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,154,605 | -23.1% | 1,197,152 | +3.1% | 0.00% | -100.0% |
Q2 2023 | $5,401,123 | +10.7% | 1,161,532 | +10.0% | 0.00% | 0.0% |
Q1 2023 | $4,880,170 | +59053.6% | 1,056,314 | +3.5% | 0.00% | 0.0% |
Q4 2022 | $8,250 | -99.8% | 1,021,079 | +20.0% | 0.00% | 0.0% |
Q3 2022 | $4,721,000 | +11.2% | 850,747 | +4.4% | 0.00% | 0.0% |
Q2 2022 | $4,245,000 | -34.5% | 814,789 | +3.3% | 0.00% | 0.0% |
Q1 2022 | $6,483,000 | -41.4% | 788,796 | +6.1% | 0.00% | 0.0% |
Q4 2021 | $11,065,000 | -15.3% | 743,679 | +7.5% | 0.00% | -50.0% |
Q3 2021 | $13,071,000 | +3.8% | 691,976 | +2.1% | 0.00% | 0.0% |
Q2 2021 | $12,598,000 | -2.3% | 677,706 | +19.6% | 0.00% | 0.0% |
Q1 2021 | $12,896,000 | +41.9% | 566,649 | +35.4% | 0.00% | 0.0% |
Q4 2020 | $9,085,000 | +182.1% | 418,519 | +30.6% | 0.00% | +100.0% |
Q3 2020 | $3,220,000 | +58.2% | 320,484 | +22.2% | 0.00% | – |
Q2 2020 | $2,035,000 | +67.1% | 262,322 | +119.6% | 0.00% | – |
Q1 2020 | $1,218,000 | -42.4% | 119,453 | -37.9% | 0.00% | – |
Q4 2019 | $2,116,000 | +152.2% | 192,432 | +108.3% | 0.00% | – |
Q3 2019 | $839,000 | -19.6% | 92,375 | +0.6% | 0.00% | – |
Q2 2019 | $1,044,000 | +71.1% | 91,793 | +71.2% | 0.00% | – |
Q1 2019 | $610,000 | -33.1% | 53,620 | -47.0% | 0.00% | – |
Q4 2018 | $912,000 | – | 101,202 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |